Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet

Journal of Nutritional Biochemistry

Volumn 23, Issue 2, 2012, Pages 192-201

  Cho, Soomin ^a   Choi, Youngshim ^a   Park, Soyoung ^a   Park, Taesun ^a  

^a Yonsei University   (South Korea)

Author keywords

Adipogenesis; Adipose tissue; Anti obesity; Carvacrol; Inflammation; Mice

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARVACROL; CYTOKINE; FIBROBLAST GROWTH FACTOR 1; GALANIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENE EXPRESSION; INFLAMMATION; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERMOGENESIS; WEIGHT GAIN; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; CELL DIFFERENTIATION; CYTOKINES; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MONOTERPENES; OBESITY; SIGNAL TRANSDUCTION; THERMOGENESIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84855503134     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.016     Document Type: Article

References (59)

1. Lazar M.A. How obesity causes diabetes: not a tall tale. Science 2005, 307:373-375.
2. Sanchez-Castillo C.P., Velasquez-Monroy O., Lara-Esqueda A., Berber A., Sepulveda J., Tapia-Conyer R., et al. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr 2005, 8:53-60.
3. Sedova L., Berube J., Gaudet D., Dumont M., Tremblay J., Hamet P., et al. Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats. Obes Res 2004, 12:1951-1958.
4. Jeusette I.C., Lhoest E.T., Istasse L.P., Diez M.O. Influence of obesity on plasma lipid and lipoprotein concentrations in dogs. Am J Vet Res 2005, 66:81-86.
5. Stunkard A.J., Allison K.C. Binge eating disorder: disorder or marker?. Int J Eat Disord 2003, 34(Suppl):S107-S116.
6. Stunkard A.J., Allison K.C. Two forms of disordered eating in obesity: binge eating and night eating. Int J Obes Relat Metab Disord 2003, 27:1-12.
7. Stunkard A.J., Faith M.S., Allison K.C. Depression and obesity. Biol Psychiatry 2003, 54:330-337.
8. Ahren B., Scheurink A.J. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 1998, 139:461-467.
9. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
10. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979, 2:131-141.
11. De Vincenzi M., Stammati A., De Vincenzi A., Silano M. Constituents of aromatic plants: carvacrol. Fitoterapia 2004, 75:801-804.
12. Enomoto S., Asano R., Iwahori Y., Narui T., Okada Y., Singab A.N., et al. Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol Pharm Bull 2001, 24:307-310.
13. Skocibusic M., Bezic N. Phytochemical analysis and in vitro antimicrobial activity of two Satureja species essential oils. Phytother Res 2004, 18:967-970.
14. Hagan E.C., Hansen W.H., Fitzhugh O.G., Jenner P.M., Jones W.I., Taylor J.M., et al. Food flavourings and compounds of related structure. II. Subacute and chronic toxicity. Food Cosmet Toxicol 1967, 5:141-157.
15. Giannenas I., Florou-Paneri P., Papazahariadou M., Christaki E., Botsoglou N.A., Spais A.B. Effect of dietary supplementation with oregano essential oil on performance of broilers after experimental infection with Eimeria tenella. Arch Tierernahr 2003, 57:99-106.
16. Akkol E.K., Avci G., Kucukkurt I., Keles H., Tamer U., Ince S., et al. Cholesterol-reducer, antioxidant and liver protective effects of Thymbra spicata L. var. spicata. JEthnopharmacol 2009, 126:314-319.
17. Chami F., Chami N., Bennis S., Trouillas J., Remmal A. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. Journal of Antimicrobial Chemotherapy 2004, 54:909-914.
18. Chami N., Chami F., Bennis S., Trouillas J., Remmal A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz J Infect Dis 2004, 8:217-226.
19. Kristinsson K.G., Magnusdottir A.B., Petersen H., Hermansson A. Effective treatment of experimental acute otitis media by application of volatile fluids into the ear canal. J Infect Dis 2005, 191:1876-1880.
20. Landa P., Kokoska L., Pribylova M., Vanek T., Marsik P. In vitro anti-inflammatory activity of carvacrol: inhibitory effect on COX-2 catalyzed prostaglandin E(2) biosynthesis. Arch Pharm Res 2009, 32:75-78.
21. Canbek M., Uyanoglu M., Bayramoglu G., Senturk H., Erkasap N., Koken T., et al. Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine 2008, 15:447-452.
22. He L., Mo H., Hadisusilo S., Qureshi A.A., Elson C.E. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 1997, 127:668-674.
23. Koparal A.T., Zeytinoglu M. Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549. Cytotechnology 2003, 43:149-154.
24. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
25. Rayalam S., Yang J.Y., Ambati S., Della-Fera M.A., Baile C.A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 2008, 22:1367-1371.
26. Park H.J., Della-Fera M.A., Hausman D.B., Rayalam S., Ambati S., Baile C.A. Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem 2009, 20:140-148.
27. Hsu C.L., Yen G.C. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem 2007, 55:1730-1736.
28. Zhou L.B., Chen M.D., Wang X., Song H.D., Yang Y., Tang J.F., et al. Effect of berberine on the differentiation of adipocyte. Zhonghua Yi Xue Za Zhi 2003, 83:338-340.
29. Lee M.S., Kim C.T., Kim I.H., Kim Y. Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytother Res 2009, 23:1088-1091.
30. Yang J.Y., Della-Fera M.A., Rayalam S., Ambati S., Hartzell D.L., Park H.J., et al. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 2008, 82:1032-1039.
31. Jenner P.M., Hagan E.C., Taylor J.M., Cook E.L., Fitzhugh O.G. Food flavourings and compounds of related structure. I. Acute oral toxicity. Food Cosmet Toxicol 1964, 2:327-343.
32. Tzameli I., Fang H., Ollero M., Shi H., Hamm J.K., Kievit P., et al. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem 2004, 279:36093-36102.
33. G. Boden. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008;37:635-46, viii-ix.
34. Han C., Wang J., Li L., Wang L., Zhang Z. The role of LXR alpha in goose primary hepatocyte lipogenesis. Mol Cell Biochem 2009, 322:37-42.
35. Taleb S., Lacasa D., Bastard J.P., Poitou C., Cancello R., Pelloux V., et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005, 19:1540-1542.
36. Taleb S., Cancello R., Clement K., Lacasa D. Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 2006, 147:4950-4959.
37. Widberg C.H., Newell F.S., Bachmann A.W., Ramnoruth S.N., Spelta M.C., Whitehead J.P., et al. Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am J Physiol Endocrinol Metab 2009, 296:E121-E131.
38. Korotayev K., Chaussepied M., Ginsberg D. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry. Cell Signal 2008, 20:1221-1226.
39. Karatayev O., Baylan J., Weed V., Chang S., Wynick D., Leibowitz S.F. Galanin knockout mice show disturbances in ethanol consumption and expression of hypothalamic peptides that stimulate ethanol intake. Alcohol Clin Exp Res 2009.
40. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 2007, 115:177-207.
41. Kanazawa T., Kommareddi P.K., Iwashita T., Kumar B., Misawa K., Misawa Y., et al. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells. Clin Cancer Res 2009, 15:2222-2230.
42. Kim A.R., Park T.S. Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice. Mol Nutr Food Res 2010, 54:1361-1370.
43. Jin W., Takagi T., Kanesashi S.N., Kurahashi T., Nomura T., Harada J., et al. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev Cell 2006, 10:461-471.
44. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
45. Pang J., Choi Y., Park T. Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys 2008, 476:178-185.
46. Wendel A.A., Purushotham A., Liu L.F., Belury M.A. Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice. Lipids 2009.
47. Lavu S., Boss O., Elliott P.J., Lambert P.D. Sirtuins - novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 2008, 7:841-853.
48. Nedergaard J., Petrovic N., Lindgren E.M., Jacobsson A., Cannon B. PPARgamma in the control of brown adipocyte differentiation. Biochim Biophys Acta 2005, 1740:293-304.
49. Gambert S., Ricquier D. Mitochondrial thermogenesis and obesity. Curr Opin Clin Nutr Metab Care 2007, 10:664-670.
50. Botelho M.A., Rao V.S., Montenegro D., Bandeira M.A., Fonseca S.G., Nogueira N.A., et al. Effects of a herbal gel containing carvacrol and chalcones on alveolar bone resorption in rats on experimental periodontitis. Phytother Res 2008, 22:442-449.
51. Sosa S., Altinier G., Politi M., Braca A., Morelli I., Della Loggia R. Extracts and constituents of Lavandula multifida with topical anti-inflammatory activity. Phytomedicine 2005, 12:271-277.
52. Hotamisligil G.S. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003, 27(Suppl 3):S53-S55.
53. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
54. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
55. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 2001, 276:16683-16689.
56. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J Biol Chem 2004, 279:16971-16979.
57. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through toll-like receptors. Mol Cells 2006, 21:174-185.
58. Hsu C.L., Yen G.C. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol Nutr Food Res 2006, 50:1072-1079.
59. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005, 338:694-699.